Clinical Trials on Paraproteinemias in United States
Total 2370 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
Becton, Dickinson and CompanyCompletedPlasma Cell DisorderSwitzerland, Spain, United Kingdom, United States, Portugal
-
Columbia UniversityGenzyme, a Sanofi CompanyRecruitingMonoclonal GammopathyUnited States
-
University of CincinnatiThe Christ HospitalWithdrawnParaproteinemias | Amyloidosis | CardiomyopathiesUnited States
-
Tufts Medical CenterTerminatedAL AmyloidosisUnited States
-
Icahn School of Medicine at Mount SinaiMillennium Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Andrew EisenbergerCompletedAmyloidosisUnited States
-
University of TennesseeFood and Drug Administration (FDA)Completed
-
University of TennesseeFDA Office of Orphan Products DevelopmentCompleted
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
Boston Medical CenterCelgene CorporationCompletedAL AmyloidosisUnited States
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
University of TennesseeCompleted
-
Indiana UniversityActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceUnited States
-
Boston Medical CenterSpectrum Pharmaceuticals, IncTerminatedAmyloidosis; SystemicUnited States
-
Mayo ClinicCompletedAmyloidosisUnited States
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
Stanford UniversityCelgene CorporationCompletedLeukemia | AmyloidosisUnited States
-
M.D. Anderson Cancer CenterSanofi US Services, IncRecruiting
-
Starton Therapeutics, IncRecruitingMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
University of ChicagoRecruiting
-
Swedish Medical CenterRecruiting
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene; Aduro Biotech, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
University of Alabama at BirminghamActive, not recruitingMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumEnrolling by invitation
-
University of VirginiaWithdrawnMultiple MyelomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteTerminatedMultiple MyelomaUnited States
-
CASI Pharmaceuticals, Inc.Completed
-
Surbhi Sidana, MDCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted
-
Emory UniversityMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
Siddhartha GangulyCompleted
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
Abramson Cancer Center of the University of PennsylvaniaTerminated
-
Attaya SuvannasankhaCelgeneCompletedLenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted